BioSpace News Archive

Drug Development

BMS Scores FDA Approval for Novel HCM Treatment Camzyos

The FDA approval was based on data from the Phase III Explorer-HCM trial that showed Bristol Myers Squibb’s Camzyos could decrease the heart’s contractility.

April 29, 2022
·
2 min read
·
Alex Keown
Drug Development

Finch Therapeutics Gets FDA Green Light to Resume CDI Therapy Trial

Finch Therapeutics has been given the green light to continue the Phase III Prism4 clinical trial, investigating the efficacy of CP101 in fighting recurrent C. difficile infections (CDI).

April 29, 2022
·
2 min read
·
Jazmine Colatriano, M.S.
Policy

China Introduces Strict New Bioethics Guidelines for Genetics Materials

China’s proposed guidelines for bioethics say that organizations outside of China cannot collect and preserve Chinese human genetic resources inside China or take them out of the country.

April 29, 2022
·
3 min read
·
Mark Terry
Business

Genocea Biosciences, Solid Biosciences Slash Headcounts in Restructuring Plans

Genocea Biosciences and Solid Biosciences are undertaking a new strategic prioritization that includes reducing their headcount.

April 29, 2022
·
3 min read
·
Alex Keown
Deals

Zymeworks Mulls $733 Million Bid from All Blue Capital

Zymeworks received an unsolicited, non-binding acquisition offer from global investment firm All Blue Capital. All Blue is offering $10.50 per share for a total of $773 million in cash.

April 29, 2022
·
3 min read
·
Mark Terry
Career Advice

How to Navigate a Career Change From Pharma to Biotech

If you’re considering a career change from pharma to biotech, you’ll be happy to hear that according to industry experts, the transition is more common than you might think.

April 29, 2022
·
6 min read
·
Christie Adams
Business

AbbVie Touts Another FDA Approval for Rinvoq, Posts Strong First Quarter

AbbVie is off to a strong start for 2022 driven by success from Skyrizi and Rinvoq, as well as the company’s neuroscience platform. Abbvie also won FDA approval for a new indication for Rinvoq.

April 29, 2022
·
4 min read
·
Alex Keown
Job Trends

Pharma Expansions: Beigene, Boehringer Ingelheim to Break Ground for New Facilities

Several biopharma companies are closing out the month of April with expansions to facilities, including a $3 billion investment to develop next-generation life science ecosystems.

April 29, 2022
·
4 min read
·
Hayley Shasteen
Drug Development

AstraZeneca Closes Busy Week With $11B in Revenue, New R&D Site

AstraZeneca topped off a very busy week with its first-quarter financial report, citing a total of $11.390 billion in revenue, a whopping increase of 60%.

April 29, 2022
·
4 min read
·
Mark Terry
Business

Veklury Skyrockets Gilead’s Q1 Earnings As Net Income Falls

Gilead’s Veklury made massive profits, but as more vaccine boosters arrive and more people become immune to the virus, the future of the antiviral is in question.

April 29, 2022
·
3 min read
·
Hannah Chudleigh